Zytoprotec's Novel Dialysis Product Meets Both Endpoints in Phase II Study
Results in double-blind Phase II trial clinically highly relevant 8 centers participated in trial with novel peritoneal dialysis fluid PD-protec® Safety profile equal to best currently available fluid Vienna, Austria, June 09, 2017 / B3C newswire / -- …